KRAS G12D inhibitor 24
Compound 103 (KRAS G12D Inhibitor 24) is a potent and orally bioavailable small molecule targeting the KRAS G12D mutation, demonstrating an IC50 of 4 nM. It is a valuable research tool for in vitro biochemical assays and in vivo studies in oncology research, particularly for investigating targeted therapies against pancreatic and colorectal cancers.
Product Specifications
CAS Number
3033701-29-7
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Smiles
C (#C) C=1C=2C (=CC (O) =CC2C=CC1F) C3=C (F) C4=C (C=N3) C (=NC (OC[C@@]5 (C) \C (=C\F) \CCN (C) C5) =N4) N6CC7NC (C6) CC7
Molecular Formula
C34H33F3N6O2
Molecular Weight
614.66
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880009-500 1x 500 µL
MART-1 / Melan-A (M2-7C10), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940960-500 1x 500 µL
MUC1 / EMA / CD227 (Epithelial Marker) (rMUC1/960), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470261-500 1x 500 µL
CD66 (CEA) (C66/261), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details